page header

Generics Lifecycle Management

IMS and The Generics Lifecycle

Watch the video to learn how IMS helps generics companies find opportunities and be first to market.

Levers of Commercial Success

Be first to market and beat the competition by using QuintilesIMS solutions to discover new generics opportunities and make timely and informed strategic market decisions across the lifecycle.

Product Selection & Development
  • Identify and select potential generics
  • Evaluate protection status
  • Understand competitor activity & positioning
  • Decide out/in licensing strategies
Launch Planning
  • Identify launch markets
  • Create product positioning
  • Build country specific pricing & reimbursement strategies
  • Forecast volume and sales
Portfolio & Geographical Expansion
  • Accelerate growth through product M&A
  • Optimize portfolio & disease strategies
  • Extend geographic presence
  • Assess competitor strategies
Performance Management
  • Manage tenders and contracts
  • Track performance across countries
  • Measure awareness and adoption
  • Align go-to-market resources

Global Country-level Drug Sales, Volume and Price Information from MIDAS

With access to MIDAS, you can identify, prioritize and size generic opportunities on a country-by-country basis to gather business intelligence: 

  • Sales, volume, price and package information for pharmaceutical products across 92 countries and 147 distribution channels
  • Global harmonization maps local product sales globally to enable direct comparison

Download Product Sheet

Learn more about IMS’s MIDAS offering

Worldwide Key Patent Intelligence from Ark

Find and assess generic opportunities faster than your competition:

  • 60,000 patent families from 130 countries related to both marketed drugs and those in late-stage development
  • Rapid identification of commercially relevant molecule patents, exclusivity data, SPC flags and constraints
  • Simple, intuitive access to complex patent landscapes means less time on search and more on decision making

Download Ark Product Sheet

Learn more about Ark Patent Intelligence

Compare Market Growth Forecasts and Track Competitor Moves

The Generic Market Insights Package provides unique intelligence on commercially-attractive geographic areas and their 5-year growth rates, helping you identify and track branded and generic competitive threats to your portfolio earlier by providing:

  • Five-year generic market forecasts for 24 countries based on unique sales data and primary market research
  • Detailed intelligence on the pricing & reimbursement approaches in 31 countries
  • Track new drug molecules across the R&D pipeline and Global product launches
  • Access to over 67,000 life science company deals, including MedTech and Generics

At-a-Glance View of The Pharma Market with Analytics LinkTM

Intuitive access to complex pharma market intelligence to discover and assess opportunity quickly with the following key features:

  • 6,700+ marketed drugs
  • 7,700+ active R&D projects
  • 335 Anatomical Therapeutic Category level 3 classes
  • The leading 350 pharmaceutical corporations
  • 71 countries including the key growth markets

Learn More

Custom Analysis of the Generic Market Tailored to Your Needs

Custom services provided by a team of experts with access to IMS's information assets, innovative methodologies and analytics:

  • Size and forecast the generic product opportunity
  • Guide your generic product development to avoid patent infringement
  • Identify technology and product licensing opportunities and competitor activities

Generics Industry Insights

Why We Need Generic Medicines Part 5: Diversification, Specialisation and Acquisition as Opportunities for Generic Company Growth

In Part 5 of this series we continue on the theme from part 4 in considering some of the potential approaches generic companies can employ to drive growth, exploring some of the notable examples of the deployment of these strategies in the market.

Why We Need Generic Medicines Part 4: Generics Market Forecast Growth and Opportunities for Generics Manufacturers

In Part 4 of this series we explore how the Generics market is forecast to grow over the coming years and what options Generics companies can consider to seize that opportunity, including growing the existing portfolio, launch of new molecules and geographic expansion.

Why We Need Generic Medicines Part 3: Patient Impact and Relative Use Across Therapy Areas

In Part 3 we explore how the availability of Generic Medicines in Europe has resulted in one of three potential benefits for patients in each country, whilst Generic Medicines have also come to dominate 10 key therapeutic areas by volume use

Why We Need Generic Medicines Part 2: Global Value and Volume Share of Generics

An overview of how Generic Medicines have taken share of volume and revenue in markets around the world between 2006 and 2015.

Why We Need Generic Medicines Part 1: The Healthcare Market and The Role of Generics

Find Quantitative insights into pharma market forecast growth around the world and variation of utilization rates of Generic Medicines in different countries.

Interested in learning more about how QuintilesIMS’s LifeCycle Management for Generics can help you succeed?  Let us know how we can help you: